The development of sarcopenia in patients with chronic liver disease has been recognized as a predictor of poor outcome. Sarcopenia, or the progressive loss of skeletal muscle mass begins to manifest in the early stages of chronic liver disease and worsens with progression to advanced liver disease with a prevalence approaching 60% in patients with end-stage liver disease (1).
No takes yet. Share an insight, caveat, or question.
Li et al. (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: